It was back in 2005 when we first reported on studies which demonstrated an increased risk of “poor neonatal adaptation” in infants with prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants in late pregnancy. [...]
Individuals with psychiatric disorders are at higher risk for obesity than the general population, as well as for medical comorbidity, such as diabetes, hypertension, hyperlipidemia, and cardiovascular disease. Moreover, many medications for psychiatric disorders worsen [...]
A few days ago, an article was published in the journal Pediatrics on neonatal morbidity observed in children exposed to antidepressants. Although this article is likely to find its way into the headlines, it is [...]
We are seeing an increasing number of women in our clinic who are using marijuana on a regular basis — recreationally and medically prescribed — to help them manage various psychiatric symptoms, including depression and [...]
The use of opioid drugs in women of childbearing age has become a pressing public health concern. It is clear that opiate use during pregnancy puts the mother and child at risk; opiate use during [...]
Multiple studies have demonstrated an increased risk of poor neonatal adaptation associated with exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants in late pregnancy. Results in the literature consistently indicate that about 25%-30% of infants [...]
Some, but not all, studies have shown an association between in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants and adverse pregnancy outcomes, including preterm delivery, low birth weight, and lower Apgar scores. [...]
Given the number of younger women using atypical antipsychotic medications, we need more accurate data regarding the reproductive safety of these medications. To better understand the link between antipsychotic medication and medical conditions associated with [...]
Second-generation or “atypical” antipsychotics, such as olanzapine (Zyprexa), aripiprazole (Abilify), and risperidone (Risperdal), are used far more frequently than are the first-generation or “typical” antipsychotics, such as haloperidol (Haldol). This is largely because the newer [...]
You can find a more recent post on this topic here: Venlafaxine and Duloxetine: Pooled Analysis Shows No Increase in Risk of Malformations We receive a fair number of questions on the use of duloxetine [...]
